ENALTEC PHARMA RESEARCH PRIVATE LIMITED

Active    As on: 31 March, 2024    Update Info    Print    Share

OVERVIEW - ENALTEC PHARMA RESEARCH PRIVATE LIMITED

Enaltec Pharma Research Private Limited is an unlisted private company incorporated on 18 May, 2005. It is classified as a private limited company and is located in Ambernath, Maharashtra. It's authorized share capital is INR 30.00 lac and the total paid-up capital is INR 14.02 lac.

Enaltec Pharma Research's operating revenues range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2020. It's EBITDA has decreased by -23.99 % over the previous year. At the same time, it's book networth has decreased by -402.33 %. Other performance and liquidity ratios are available here.

Description: This company manufactures, and supplies active pharmaceutical ingredient (API). It provides dronedarone hydrochloride, Phytonadione (Vitamin K1), felbamate, felbamate, and midodrine hydrochloride

Products & Services: regulated products, such as Dronedarone Hydrochloride, Phytonadione (Vitamin K1), Felbamate, and Midodrine Hydrochloride; and semi regulated products, Eletriptan Hydrobromide, and Olanzapine
Category: Manufacturer

The current status of Enaltec Pharma Research Private Limited is - Active.

The last reported AGM (Annual General Meeting) of Enaltec Pharma Research Private Limited, per our records, was held on 25 August, 2023.

Enaltec Pharma Research Private Limited has six directors - Anand Prafulchandra Shah, Amit Bansilal Jain, and others.

The Corporate Identification Number (CIN) of Enaltec Pharma Research Private Limited is U24230MH2005PTC153404. The registered office of Enaltec Pharma Research Private Limited is at Plot No PL-11, MIDC, Addl Ambernath NA, , Ambernath, Maharashtra.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more

REGISTERED DETAILS - ENALTEC PHARMA RESEARCH PRIVATE LIMITED


CIN

U24230MH2005PTC153404

Incorporation Date / Age

18 May, 2005 / 19 yrs

Last Reported AGM Date

25 August, 2023


Authorized Capital

INR 30.0 Lacs

Paidup Capital

INR 14.0221 Lacs

industry*

Manufacturing (Chemicals and chemical products)


type

Unlisted Private Company

category

Company limited by Shares

subcategory

Non-govt company


Email Address

Login for email address. This is to prevent spam.

Website

http://enaltec.com/. (Incorrect website?)

Registered Address

Plot No PL-11, MIDC, Addl Ambernath NA

Ambernath - 421506
Maharashtra - India


How to download ENALTEC PHARMA RESEARCH PRIVATE LIMITED report

A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.

ENALTEC PHARMA RESEARCH PRIVATE LIMITED - Registration Details
CINU24230MH2005PTC153404
Incorporation Date / Age18 May, 2005 / 19 yrs
Last Reported AGM Date25 August, 2023
Authorized CapitalINR 30.0 Lacs
Paidup CapitalINR 14.0221 Lacs
industry*Manufacturing (Chemicals and chemical products)
typeUnlisted Private Company
categoryCompany limited by Shares
subcategoryNon-govt company
Email Address
Websitehttp://enaltec.com/
Registered AddressPlot No PL-11, MIDC, Addl Ambernath NA  Ambernath - 421506 Maharashtra - India

FINANCIAL HIGHLIGHTS - ENALTEC PHARMA RESEARCH PRIVATE LIMITED

Provided here are the financial indicators for financial year ending on 31 March, 2020. Actual numbers and updated financial data are included in purchased financial report.
View Sample Report.
Operating Revenue INR 1 cr - 100 cr
EBITDA -23.99 %
Networth -402.33 %
Debt/Equity Ratio -2.25
Return on Equity N/A

* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.

How to get financial reports of ENALTEC PHARMA RESEARCH PRIVATE LIMITED

Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.

Directors - ENALTEC PHARMA RESEARCH PRIVATE LIMITED

The company has 6 directors and no reported key management personnel.


The longest serving director currently on board is Anand Prafulchandra Shah who was appointed on 12 September, 2009. Anand Prafulchandra Shah has been on the board for more than 14 years. The most recently appointed director is Neeraj Singh, who was appointed on 06 May, 2023.


Sumit Gupta has the largest number of other directorships with a seat at a total of 12 companies. In total, the company is connected to 18 other companies through its directors.


NAME DESIGNATION APPOINTMENT DATE
ANAND PRAFULCHANDRA SHAH Director 12 September, 2009 Other directorships - GENLINK PHARMA INVESTMENTS PRIVATE LIMITED,  GENLINK PHARMA LLP,  ENALTEC LABS PRIVATE LIMITED, 
AMIT BANSILAL JAIN Director 14 February, 2022 Other directorships - STANFORD LABORATORIES PRIVATE LTD,  VEDELIK HEALTHCARE PRIVATE LIMITED,  ENALTEC LABS PRIVATE LIMITED,  RUSOMA HEALTHCARE PRIVATE LIMITED, 
SAMIR KUMAR Director 14 February, 2022 Other directorships - ENALTEC LABS PRIVATE LIMITED,  LA RENON HEALTHCARE PRIVATE LIMITED, 
VIVEK GUPTA Director 14 February, 2022 Other directorships - ENALTEC LABS PRIVATE LIMITED,  LA RENON HEALTHCARE PRIVATE LIMITED, 
SUMIT GUPTA Director 30 March, 2017 Other directorships - GENEFACT PRIVATE LIMITED,  SUNWAYS (INDIA) PRIVATE LIMITED,  PREGNA INTERNATIONAL LIMITED,  SYMBIOTEC LIFESCIENCES PRIVATE LIMITED,  KNOVEA PHARMACEUTICAL PRIVATE LIMITED,  INVENGENE LIMITED,  ENALTEC LABS PRIVATE LIMITED,  SYMBIOTEC PHARMALAB PRIVATE LIMITED,  ACCUMAX LAB DEVICES PRIVATE LIMITED,  NUTRIVENTIA LIMITED,  INVENTIA HEALTHCARE LIMITED, 
NEERAJ SINGH Director 06 May, 2023 Other directorships - FRIMLINE PRIVATE LIMITED,  STANFORD LABORATORIES PRIVATE LTD,  VEDELIK HEALTHCARE PRIVATE LIMITED,  ENALTEC LABS PRIVATE LIMITED,  RUSOMA HEALTHCARE PRIVATE LIMITED, 
NAME DESIGNATION APPOINTMENT DATE
ANAND PRAFULCHANDRA SHAH Director 12 September, 2009 View other directorships
AMIT BANSILAL JAIN Director 14 February, 2022 View other directorships
SAMIR KUMAR Director 14 February, 2022 View other directorships
VIVEK GUPTA Director 14 February, 2022 View other directorships
SUMIT GUPTA Director 30 March, 2017 View other directorships
NEERAJ SINGH Director 06 May, 2023 View other directorships
12 September, 2009
30 March, 2017

SUMIT GUPTA

Director

14 February, 2022
14 February, 2022

SAMIR KUMAR

Director

14 February, 2022

VIVEK GUPTA

Director

06 May, 2023

NEERAJ SINGH

Director

Bank-wise Biggest Charges on Assets

See more...

Previous Names

GETZ PHARMA PRIVATE LIMITED
GETZ PHARMA RESEARCH PRIVATE LIMITED

Previous CINs

No previous CINs were found for this company.

SIMILAR COMPANIES

NAME INCORPORATION YEAR STATE PAID UP CAPITAL
JAIN WAX REFINARIES PRIVATE LIMITED It was formed in year 1982 in Jharkhand . The company currently has a paid up capital of INR 14.02 lac.
1982 Jharkhand 14.02 lac Buy financial reports
WEISHORN PHARMACEUTICALS PRIVATE LIMITED It was formed in year 1999 in Delhi . The company currently has a paid up capital of INR 14.02 lac.
1999 Delhi 14.02 lac Buy financial reports
VINAYAK REMEDIES LIMITED It was formed in year 2006 in Delhi . The company currently has a paid up capital of INR 14.00 lac.
2006 Delhi 14.00 lac Buy financial reports
SANVIK LABORATORIES PRIVATE LIMITED It was formed in year 2005 in Maharashtra . The company currently has a paid up capital of INR 14.00 lac.
2005 Maharashtra 14.00 lac Buy financial reports
LIFENESS PHARMACY LIMITED It was formed in year 2022 in Maharashtra . The company currently has a paid up capital of INR 14.00 lac.
2022 Maharashtra 14.00 lac Buy financial reports
ALFA CAPS PRIVATE LIMITED It was formed in year 2004 in Punjab . The company currently has a paid up capital of INR 14.00 lac.
2004 Punjab 14.00 lac Buy financial reports
IGNIVA MARKETING PRIVATE LIMITED It was formed in year 2007 in West Bengal . The company currently has a paid up capital of INR 14.00 lac.
2007 West Bengal 14.00 lac Buy financial reports
SMARTLAB PERFORMAX PRIVATE LIMITED It was formed in year 2021 in Assam . The company currently has a paid up capital of INR 14.00 lac.
2021 Assam 14.00 lac Buy financial reports
NARANA CABLES AND CHEMICALS PHARMACEUTICALS PRIVATE LIMITED It was formed in year 1990 in Maharashtra . The company currently has a paid up capital of INR 14.00 lac.
1990 Maharashtra 14.00 lac Buy financial reports
LALCO PHARMA PRIVATE LIMITED It was formed in year 2000 in Delhi . The company currently has a paid up capital of INR 14.00 lac.
2000 Delhi 14.00 lac Buy financial reports

SUBSIDIARY COMPANIES

No Indian subsidiary companies found.

Company Network - ENALTEC PHARMA RESEARCH PRIVATE LIMITED

Company Network • Tofler Business Research Platform
How to use company network of ENALTEC PHARMA RESEARCH PRIVATE LIMITED

Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.

FAQ - ENALTEC PHARMA RESEARCH PRIVATE LIMITED

  • What is the Incorporation date of ENALTEC PHARMA RESEARCH PRIVATE LIMITED?

    The Incorporation Date of ENALTEC PHARMA RESEARCH PRIVATE LIMITED is 18 May, 2005.

  • What is the operating revenue of ENALTEC PHARMA RESEARCH PRIVATE LIMITED?

    The operating revenue of ENALTEC PHARMA RESEARCH PRIVATE LIMITED is in the range of INR 1 cr - 100 cr for the financial year ending on 31 March, 2020.

  • What is the change in EBITDA of ENALTEC PHARMA RESEARCH PRIVATE LIMITED since last year?

    The EBITDA of ENALTEC PHARMA RESEARCH PRIVATE LIMITED has decreased by -23.99 % over the previous year. At the same time, it's book networth has decreased by -402.33 % for the financial year ending 31 March, 2020.

  • What is the business of ENALTEC PHARMA RESEARCH PRIVATE LIMITED?

    This company manufactures, and supplies active pharmaceutical ingredient (API). It provides dronedarone hydrochloride, Phytonadione (Vitamin K1), felbamate, felbamate, and midodrine hydrochloride.

  • Which Products and Services are provided by ENALTEC PHARMA RESEARCH PRIVATE LIMITED?

    The products and services offered by ENALTEC PHARMA RESEARCH PRIVATE LIMITED are regulated products, such as Dronedarone Hydrochloride, Phytonadione (Vitamin K1), Felbamate, and Midodrine Hydrochloride; and semi regulated products, Eletriptan Hydrobromide, and Olanzapine.

  • Who are the directors of ENALTEC PHARMA RESEARCH PRIVATE LIMITED?

    Enaltec Pharma Research Private Limited has six directors - Anand Prafulchandra Shah, Amit Bansilal Jain, and others.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more



Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More